Research university Leverage Ospedale San Raffaele’s integration of research, medicine, and university education to position advanced clinical trials, translational research services, and education collaborations with pharma and biotech partners.

CRISPR & genetics Target opportunities in CRISPR-based therapies and genetic disease programs, highlighting public collaborations and potential co-development or licensing deals with biotech firms seeking access to cutting-edge gene-editing platforms.

Breast cancer leadership Capitalize on participation in high-profile oncology congresses (ESMO Breast Cancer) and ongoing HER2-positive breast cancer research to offer companion diagnostics, clinical trial enrollment programs, or payer-ready treatment optimization solutions.

Microbiome research Explore partnerships around microbiome-directed therapies for multiple myeloma progression prevention, aligning with biotech startups or pharma firms focused on microbiome modulation and innovative preventive strategies.

Regional scale With a substantial hospital network under Gruppo San Donato and a mid-to-upper revenue band, pursue enterprise healthcare IT, patient engagement platforms, and data analytics services to optimize outcomes, reduce toxicity, and demonstrate value-based care in large patient cohorts.